Big Pharma and the Next Congress

In addition to the obvious legal questions involved in the pharmaceutical immunity case of Bruesewitz v. Wyeth, this case also has a political component that ties it to the midterm elections. If the Supreme Court interprets the Vaccine Act in a way that benefits injured parties, we can expect the giant pharmaceutical companies to push the next Congress to change the law. That would connect this case politically, if not legally, to Citizens United and the DISCLOSE Act.

As detailed in a recent People For report, powerful corporations, unleashed by the Roberts Court, are taking aim at our democracy and spending millions of dollars under cover of anonymity in order to purchase a pliant Republican congressional majority. Republican members of Congress will surely know who they can thank for their offices, but without the transparency rules included in the DISCLOSE Act, blocked by Republicans in Congress, ordinary Americans will have no way of knowing if the pharmaceutical companies are among the corporate sponsors of the newly elected Republican caucus.

That is one of the many reasons we must pass the DISCLOSE Act.